Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN OPHTHALMOLOGY

 Salmon color sub-epithelial infiltration
Salmon color sub-epithelial infiltration. AS-OCT: Subepithelial hypo reflective infiltrative lesion.

June 2023

OPHTHALMOLOGY

CASE REPORT: EXTRANODAL MARGINAL ZONE LYMPHOMA OF THE OCULAR ADNEXA

By: R. Chris Bowen, MD
A 54-year-old man presented to Northwestern Medicine Ophthalmology with right eye pain and blurred vision. A clinical exam revealed intraocular pressure (IOP) of 35 mmHg in the right eye and 11 mmHg in the left eye, and a salmon colored sub-epithelial conjunctival infiltration and a diffusely shallow anterior chamber in the right eye, and a normal anterior segment in the left eye.

​​Ocular ultrasonography showed massive orbital as well was choroidal infiltration extending into the ciliary body. A biopsy of the lesion confirmed extranodal marginal zone lymphoma (MALT lymphoma).  Systemic evaluation with PET/CT while body imaging and MRI of the brain/orbit showed only right eye/orbit involvement. Our expert radiation oncologist treated the patient with radiation therapy of the right orbit with 24 Gy in 12 fractions. They based their treatment selection on published data showing a local control rate of 96%. Additionally, this low dose is typically well tolerated by patients. 
​
These physicians collaborated in the diagnosis and treatment of this patient:
  • R. Chris Bowen, MD, Ophthalmic Oncology
  • Eric Donnelly, MD, Radiation Oncology
  • Jayesh Mehta, MD, Oncology
  • Angelo P. Tanna, MD, Ophthalmology
 
The patient’s sight-threatening angle closure and massive uveal infiltration has resolved. Three months later, his vision is 20/25 and he is very happy.
 
This case illustrates the strength of our multidisciplinary approach in managing the most complex ophthalmology cases.

Angle closure pre and post radiation
uveal infiltration pre and post radiation

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM Ophthalmologist

You May Also Like

person getting phon beam therapy

November 2022

OPHTHALMOLOGY
Proton Beam Therapy and Plaque Brachytherapy for Uveal Melanoma
Liza Cohen, MD, and Stephen Magill, MD, PhD headhsots

May 2022

OPHTHALMOLOGY
Case Report: Pulsatile Proptosis Due To Orbitocranial Trauma
David J. Palmer, MD headshot

November 2022

OPHTHALMOLOGY
Sustainable Ophthalmology: Waste Management in the OR

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties